A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
Tison, François, Keywood, Charlotte, Wakefield, Mark, Durif, Franck, Corvol, Jean-Christophe, Eggert, Karla, Lew, Mark, Isaacson, Stuart, Bezard, Erwan, Poli, Sonia-Maria, Goetz, Christopher G., TrenkLanguage:
english
Journal:
Movement Disorders
DOI:
10.1002/mds.26659
Date:
May, 2016
File:
PDF, 294 KB
english, 2016